Pediatrix reaffirms 2026 adjusted EBITDA outlook of $280M-$300M as pricing outpaces modest volume declines

EarningsPositive

AI Analysis

Pediatrix reaffirmed its 2026 adjusted EBITDA guidance of $280M-$300M, with pricing increases offsetting modest volume declines.

Guidance

$280M-$300M adjusted EBITDA (2026)

Importance:4/10

Sentiment:

0.30

guidanceearningsadjusted EBITDApricing strengthvolume decline

Related Companies

Read the original article

Published by Seeking Alpha Healthcare on May 5, 2026 3:32 PM